IRD

Opus Genetics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Foundation Fighting Blindness Retinal Degeneration FundDirector, Other: See Remarks
$8.6M4M shares
SellDec 9, 2025
$2.15
--
Gallagher CamDirector
$163k83k shares
BuyDec 29, 2025
$1.97
--
Gallagher CamDirector
$160k81k shares
BuyDec 29, 2025
$1.98
--
Jayagopal AshwathChief Scientific & Dev. Ofc.
$19k3.7k shares
SellMar 16, 2026
$5.12
--
Magrath GeorgeDirector, Officer: Chief Executive Officer
$127k24.4k shares
SellMar 16, 2026
$5.21
--
Zaremba Rabourn AmyHead Of Fin. Quality Assurance
$15k2.8k shares
SellMar 16, 2026
$5.25
--

News

seekingalpha.comOpus Genetics, Inc. (IRD) Discusses Early-Stage Gene Therapy Programs and Clinical Strategies for Inherited Retinal Diseases Transcriptseekingalpha.comJun 17globenewswire.comOpus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseasesglobenewswire.comJun 16globenewswire.comOpus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Expertsglobenewswire.comJun 2globenewswire.comOpus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Expertsglobenewswire.comJun 2globenewswire.comOpus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comMay 28